JPH03153610A - Skin-beautifying cosmetic - Google Patents

Skin-beautifying cosmetic

Info

Publication number
JPH03153610A
JPH03153610A JP29369689A JP29369689A JPH03153610A JP H03153610 A JPH03153610 A JP H03153610A JP 29369689 A JP29369689 A JP 29369689A JP 29369689 A JP29369689 A JP 29369689A JP H03153610 A JPH03153610 A JP H03153610A
Authority
JP
Japan
Prior art keywords
skin
cosmetic
effect
ascorbic acid
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP29369689A
Other languages
Japanese (ja)
Inventor
Misa Shinoki
篠木 美砂
Toshio Hikima
俊雄 引間
Kiyoshi Maeno
清 前野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP29369689A priority Critical patent/JPH03153610A/en
Publication of JPH03153610A publication Critical patent/JPH03153610A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain a skin-beautifying cosmetic free from skin irritation and having an effect to suppress melanogenesis and an effect to quickly bleach dark skin by using a vitamin E derivative of azelaic acid and an L-ascorbic acid derivative as essential components. CONSTITUTION:The objective cosmetic can be prepared by compounding 0.1-5wt.% of vitamin E derivative of azelaic acid or its salt and 0.2-10wt.% (in total) of one or more substances selected from L-ascorbic acid sulfuric acid ester salts and L-ascorbic acid phosphoric acid ester salts to known cosmetic base having the form of cream, milky lotion or lotion and forming the obtained mixture in the form of cosmetic by conventional method. The cosmetic may be properly compounded with colorant, perfumery, preservative, antioxidant, surfactant, skin-nourishing agent, pigment, etc. The skin-beautifying effect can be further improved especially by applying the cosmetic quickly after the exposure to sunlight, etc.

Description

【発明の詳細な説明】 (技術分野) 本発明は、皮膚安全性に優れ、皮膚が色黒になるのを予
防する効果と、色黒の皮膚を速かに淡色化する効果を有
する美白化粧ギ4に関する。
Detailed Description of the Invention (Technical Field) The present invention provides a skin-whitening cosmetic that is excellent in skin safety, has the effect of preventing skin from becoming dark-skinned, and has the effect of quickly lightening dark-skinned skin. Regarding Gi 4.

(従来技術) 日焼けによる色黒の皮INは、皮1コ内に存在するチロ
シンがチロシナーゼの作用により酸化されてメラニン色
素となり、このメラニンが過剰に生成することに起因す
るとされている。この色素沈着を予防或いは治療すべく
、従来よりL−アスコルビン酸及びその誘導体5コロイ
ド状硫黄、過酸化水素、ハイドロキノン等を配合してな
る美白化粧料がIzされている。しかし、これらの美白
化粧料は、保存安定性が不充分であるか、或いは美白効
果が充分に認められないものであったり、または、色黒
の皮膚を淡色化する効果を認めろれるが、皮膚安全性上
に問題が生しるものであって、優れた美白化粧料を得る
ことは困難であった。
(Prior Art) Dark skin IN caused by sunburn is said to be caused by the fact that tyrosine present in one skin is oxidized to melanin pigment by the action of tyrosinase, and this melanin is produced in excess. In order to prevent or treat this pigmentation, whitening cosmetics containing L-ascorbic acid and its derivative 5 colloidal sulfur, hydrogen peroxide, hydroquinone, etc. have been developed. However, these whitening cosmetics have insufficient storage stability, or do not have sufficient whitening effects, or may have the effect of lightening dark skin, but may This poses a safety problem, and it has been difficult to obtain an excellent whitening cosmetic.

(発明の開示) そこで、本発明者らは、■表皮に過剰に存在するメラニ
ンを速かに排除すること、■新たに皮膚内にメラニンが
生成することを抑制すること、■しかも、皮膚安全性上
に問題がないこと等を満足する美白化粧料を目的として
、説、口研究した結果、後記、特定の組成からなる美白
化粧料が上記の目的を達成することを見出し、本発明を
完成した。
(Disclosure of the Invention) Therefore, the present inventors have aimed to: 1) rapidly eliminate melanin present in excess in the epidermis, 2) suppress new melanin generation within the skin, and 2) ensure skin safety. As a result of theoretical and oral research with the aim of creating a whitening cosmetic that satisfies the requirements such as having no sexual problems, the present invention was completed by discovering that a whitening cosmetic with a specific composition can achieve the above objectives. did.

(発明の目的) 即ら、本発明の目的は、皮膚刺激がなく、メラニン色素
形成抑制効果と色黒の皮膚を速やかに淡白化する効果を
有する優れた美白化粧料を提供するにある。
(Object of the Invention) That is, the object of the present invention is to provide an excellent whitening cosmetic that does not cause skin irritation, has the effect of inhibiting melanin pigment formation, and has the effect of rapidly whitening dark skin.

(発明の構成) 本発明はアゼライン酸のビタミンE SA ’L体及び
その塩類の少なくとも一種と、L−アスコルビンM 6
g Mエステル塩類及びし−アスコルビン酸1ノン酸エ
ステル塩類の少なくとも一種とを含肩してなる美白化粧
料である。
(Structure of the Invention) The present invention provides vitamin E SA 'L form of azelaic acid and at least one of its salts, and L-ascorbine M6.
A whitening cosmetic containing at least one of gM ester salts and mono-ascorbic acid ester salts.

(構成の具体的な説明) 本発明に用いるアゼライン酸のヒ゛タミンE誘導体及び
その塩類は特開昭50−106965号公fg r ト
コフェロール酸性コハク酸エステルの製造法」の記載に
準じて製造可能であり、ビタミンE活性を有する物質で
ある。ビタミンEは、4体または41体のα、β、T、
δ等の異性体のし\ずれも使用が可能である。また、ア
ゼライン酸のビタミンE誘導体としてはモノエステルと
ジエステJしが存在し、モノエステル塩類を構成する塩
基としてナトリウム、カリウム5 カルシニウム、マク
゛ネシェウム、或いは、アンモニウム、アルカノ−Jレ
アミノ類、塩基性アミノ酸類などが挙げられる。
(Specific explanation of composition) The azelaic acid vitamine E derivative and its salts used in the present invention can be produced according to the description in JP-A-50-106965 fgr "Production method of tocopherol acidic succinate ester". , is a substance with vitamin E activity. Vitamin E has 4 or 41 forms α, β, T,
It is also possible to use isomers such as δ. In addition, as vitamin E derivatives of azelaic acid, there are monoesters and diesterols, and the bases constituting the monoester salts include sodium, potassium, calcium, magnesium, ammonium, alkano-J rare amino acids, and basic amino acids. Examples include.

アスコルビン酸硫酸エステル塩類及びアスコルビン酸リ
ン酸エステル塩類は公知の物質であってその塩類を構成
する塩基としては、同様にナトリウム、カリウム、カル
シュウム、マグネシュウム或いはアンモニウム、アルカ
ノールアミン類、塩基性アミノ酸類などが挙げられる。
Ascorbic acid sulfate ester salts and ascorbic acid phosphate ester salts are known substances, and the bases constituting the salts include sodium, potassium, calcium, magnesium, ammonium, alkanolamines, basic amino acids, etc. Can be mentioned.

本発明者らは、化粧料基剤中にアゼライン酸のビタミン
E誘導体及びその塩類(以下、VEAZ類と略記する)
とし−アスコルビン酸硫酸エステル塩類及びL−アスコ
ルビン酸リン酸エステル塩類(以下、AC−3t、AC
−Pt類と略記する)とが共存することによって、それ
らの個々の作用効果とくらべて、顕著に優れた(口乗効
果を発揮することを確認し本発明を完成するに至った。
The present inventors have discovered that vitamin E derivatives of azelaic acid and their salts (hereinafter abbreviated as VEAZs) are incorporated into cosmetic bases.
Toshi-ascorbic acid sulfate ester salts and L-ascorbic acid phosphate ester salts (hereinafter referred to as AC-3t, AC
The present invention was completed by confirming that the coexistence of Pt (hereinafter abbreviated as "Pt") exhibits a significantly superior oral effect compared to their individual effects.

即ち、VE−AZ類の皮膚組織を賦活して、角質層のタ
ーンオーバ速度を促進し、かつメラニンを角質層と共に
速かに排除して色黒の皮膚を淡色化する効果と、前記の
AC−3L−AC−P L類の潜在する皮膚のメラニン
形成能を抑制し、新たに色黒の皮膚となることを予防す
る効果とが相乗して、皮膚生理学上に好ましい条件下で
色黒の皮膚を淡色化する効果を発現することが新たに認
められた。
That is, the effect of activating the skin tissue of VE-AZ, accelerating the turnover rate of the stratum corneum, and rapidly eliminating melanin together with the stratum corneum to lighten dark skin, and the above-mentioned AC. -3L-AC-PL The effect of suppressing the latent melanin-forming ability of the skin and preventing new dark-skinned skin is synergistic, and under conditions favorable to skin physiology, dark-skinned skin can be reduced. It has been newly discovered that it has the effect of lightening the skin.

よって、本発明の美白化粧料は、太陽光に曝された後の
色1里になる以前の皮膚または色黒となった皮膚を対象
として、特に皮膚生理学上不安定となった皮膚に譬布し
、皮膚刺激を生しることなく、皮膚色が黒色化すること
、或いは色黒の皮膚を淡色化することに於いて、顕著な
効果を呈するものである。
Therefore, the whitening cosmetic of the present invention is intended for use on skin that has not reached a certain level of color after exposure to sunlight or skin that has become dark-skinned, and particularly for skin that has become physiologically unstable. However, it exhibits a remarkable effect in blackening the skin color or lightening dark skin without causing skin irritation.

本発明の1白化粧料は、VE−AZ類と、前記のAC−
5t −AC−P Llを周知のクリーム類乳l夜類1
 ローションtnである化粧料基剤に、通常の方法にて
、配合して調製される。
The 1 white cosmetic of the present invention comprises VE-AZs and the above-mentioned AC-
5t-AC-P Ll is a well-known cream milk type 1
It is prepared by blending it into a cosmetic base, which is lotion tn, in a conventional manner.

VE−AZ頚の含有量は、当該化粧料の総量を基準とし
て、0.1〜5重量%(以下、wt%と略記する)、ま
た、前記のAC−3t −AC−P を頚の含有量は、
各々の単独または徂合せの合計量で0.2〜10.0 
w t%であればよい。これらの含有〒の上限を超えて
もその超えた含frfflに見合つた効果は期待できず
、また下限未満の含有■では、本発明の目的を達成する
に至らないものである。
The content of the VE-AZ neck is 0.1 to 5% by weight (hereinafter abbreviated as wt%) based on the total amount of the cosmetic, and the content of the above AC-3t -AC-P in the neck is 0.1 to 5% by weight (hereinafter abbreviated as wt%). The amount is
0.2 to 10.0 in total amount of each alone or in combination
It is sufficient if it is wt%. Even if the upper limit of these contents (〒) is exceeded, no effect commensurate with the higher content (frffl) can be expected, and if the content (2) is less than the lower limit, the object of the present invention cannot be achieved.

尚、本発明の美白化粧料には、色素、香料、防腐剤、抗
酸化剤、界面活性剤、皮膚栄養剤、 111料等を本発
明の目的を達成する範囲内で適宜配合することができる
The whitening cosmetic of the present invention may contain pigments, fragrances, preservatives, antioxidants, surfactants, skin nutrients, 111 ingredients, etc. as appropriate within the scope of achieving the purpose of the present invention. .

(実施例) 以下、実施例にて本発明を説明する。(Example) The present invention will be explained below with reference to Examples.

尚、実施例に記載の■皮膚刺激試験、■角質層のターン
オーバー速度測定試験、■皮膚色明度回復試験、■美白
実用試験を下記に示す。
In addition, 1) skin irritation test, 2) stratum corneum turnover rate measurement test, 2) skin color brightness recovery test, and 2) whitening practical test described in Examples are shown below.

■ 皮膚刺激試験 夏期の太陽光に6時間(1日3時間で2日間)曝された
?lI検者25名の前椀屈側部皮膚に、試料0.05 
gを直径1. Q c mの円型のリント布のついたバ
ッチテスト用絆創膏を用いて24時間閉塞貼布した後、
下記の判定基準に従い、各試料について被検者25名の
皮膚の状、嘘を評価判定した0判定結果は、絆創膏除去
1時間後及び24時間後のうち反応の強い方を採用し、
評価が(±)以上の人の数で示した。
■ Skin irritation test: Exposure to sunlight for 6 hours (3 hours a day for 2 days) in summer? Sample 0.05 was applied to the anterior arm flexor skin of 25 II examiners.
g is the diameter 1. After applying an occlusive patch for 24 hours using a batch test bandage with a circular lint cloth of Qcm,
According to the following criteria, each sample was evaluated for the condition of the skin of 25 subjects, and the 0 result was determined by taking the stronger reaction between 1 hour and 24 hours after the removal of the bandage.
It is indicated by the number of people who gave an evaluation of (±) or higher.

■ 角質層のターンオーバー速度測定試験螢光色素のダ
ンジルクロライドを白色ワセリン中に5wt%配合した
軟膏を作り、被検者20名の前椀屈側部の皮膚に24時
間閉塞貼布し、角質層にダンジルクロライドを浸透結合
させる。その後同じ部位に1日2回(朝2り)被検試料
を塗布し、毎日ダンジルクロライドの螢光をしらぺ、そ
の螢光が消滅するまでの日数を皮膚角質層のターンオー
バー速度とした。測定結果は各被検者の日数の平均値で
示した。
■ Test for measuring the turnover rate of the stratum corneum. An ointment containing 5 wt% of the fluorescent dye danzyl chloride in white petrolatum was prepared, and an ointment was applied to the skin of the anterior arm of 20 subjects for 24 hours. Penetrates and binds danzyl chloride to the stratum corneum. After that, the test sample was applied to the same area twice a day (twice in the morning), and the fluorescence of danzyl chloride was detected every day.The number of days until the fluorescence disappeared was determined as the turnover rate of the skin stratum corneum. . The measurement results were shown as the average value of the number of days for each subject.

なお、通常の皮膚角質層のターンオーバー速度は、14
〜16日である。
Note that the normal turnover rate of the stratum corneum of the skin is 14
~16th.

■ 皮膚色明度回復試験 被試験820名の背部皮膚にUV−B領域の紫外線を最
小紅斑量の2倍量照射し、1週間の後、その照射部に試
料塗布部位と非塗布部位とを設定して各々の皮膚の基準
明度(Vo(a−Vo’値)を測定した。引続いて塗布
部位には試ネ:)を1日1回ずつ3ケ月間連Vi塗布し
、38.13週間後の塗布部位及び非塗布部位の皮膚の
明度(Vn・・・値、Vn’・・・値)を測定して、下
記の測定基準により、皮膚色の回復評価を実施した。
■ Skin color brightness recovery test The back skin of 820 test subjects was irradiated with ultraviolet light in the UV-B region at twice the minimum amount of erythema, and after one week, sample application areas and non-application areas were set in the irradiated areas. Then, the reference brightness (Vo (a-Vo' value)) of each skin was measured.Subsequently, a sample Vi was applied to the application site once a day for 3 months for 38.13 weeks. The brightness (Vn value, Vn' value) of the skin at the application site and non-application site after application was measured, and recovery of skin color was evaluated based on the following measurement criteria.

尚、皮膚の明度(マンセル表色系V(直)は高速分光色
彩計で測定して得られたX、Y、Z(直より算出した。
In addition, the brightness of the skin (Munsell color system V (direct) was calculated from X, Y, Z (direct) obtained by measurement with a high-speed spectrocolorimeter.

また、評価は被試験者20名の判  定  基  準 ■ 美白実用試験 1朋の太陽光に3時間(1日1.5時間で2日間) I
lされたPlj、検者20名の前腕圧側部皮膚を対象と
して、左前腕屈側部には太陽光に曝された口の翌日より
、また右前腕屈側部には太陽光に曝された口の7日後よ
り各々試料を朝夕1回ずつ13週間連Vt塗布した。
The evaluation was based on the judgment of 20 test subjects. ■ Whitening Practical Test 1 Exposure to direct sunlight for 3 hours (1.5 hours a day for 2 days) I
The skin on the lateral side of the forearm of 20 examiners was tested. Seven days later, each sample was applied with Vt once in the morning and once in the evening for 13 weeks.

評価は、試料を塗布した皮膚の部分が他の皮膚の部分よ
り色白となった(淡色化)と回答した被検者の数で示し
た。
The evaluation was expressed by the number of subjects who answered that the area of the skin to which the sample was applied became fairer (lightening) than other areas of the skin.

実施例1. 2  比較例1.2 〔スキンローション〕 下記の組成に於いて、第1表に示す通りにVE−AZ類
及びAC−3L・AC−Pt類の含有量を変えて、各々
のスキンローションを調型して本試験を実施した。その
結果を第1表に示した。
Example 1. 2 Comparative Example 1.2 [Skin lotion] In the following composition, each skin lotion was prepared by changing the content of VE-AZ and AC-3L/AC-Pt as shown in Table 1. This test was carried out using a model. The results are shown in Table 1.

尚、ビタミンE−アゼライン酸モノエステルのカルシュ
ラム塩をV B −A Z +  −Ca 、  ビタ
ミンE−アゼライン酸ジエステルをVE−AZ、、L−
アスコルビン酸−2−硫酸エステルナトリウム塩をAC
−2−3L−Na、L−アスコルビン酸−3−硫酸エス
テルトリエタノールアミン塩をAC−3−3t−TEA
、L−アスコルビン酸2−リン酸エステルマグネシュウ
ム塩をAC−2−Pt−Mg、及びL−アスコルビンM
−3−リン酸エステルリジン塩をAC−3−Pt−Lg
のごとく略記する。
In addition, the calcium salt of vitamin E-azelaic acid monoester is V B -AZ + -Ca, and the vitamin E-azelaic acid diester is VE-AZ, , L-
Ascorbic acid-2-sulfate ester sodium salt as AC
-2-3L-Na, L-ascorbic acid-3-sulfate ester triethanolamine salt with AC-3-3t-TEA
, L-ascorbic acid 2-phosphate ester magnesium salt, AC-2-Pt-Mg, and L-ascorbic acid M
-3-phosphate ester lysine salt is AC-3-Pt-Lg
It is abbreviated as follows.

0)11成 +21  jl製法 全原料成分を均一に7容解した後、容器に充填する。0) 11 years old +21 jl manufacturing method After uniformly dissolving all the raw material components in 7 volumes, fill them into a container.

(31特性 第1表に示すごとく、スキンローションW 剤にV巳−
へZ類またはAC−3t −AC−P Lfftを各々
単独で含存するスキンローション(比較例1.2)では
角n層ターンオーバー速度がやや速くなり日数が減少す
る効果が認められるが、皮膚色明度回復試験及び美白実
用試験に於いて充分なる効果は得られない、実に例1〜
20本発明の美白化粧料は諸:Xu、の5F価がすべて
良好であり、特に太陽光にB3された口の翌日より、過
剰のメラニンが皮f5内に形成される以Φ1に試料を塗
布した左前腕部の皮膚は、色黒の皮膚を予防する効果が
明らかに認められて、右前腕部に比較して美白効果が向
上している。
(31 characteristics As shown in Table 1, the skin lotion W agent contains
The skin lotion containing He Z or AC-3t-AC-P Lfft alone (Comparative Example 1.2) has the effect of slightly increasing the turnover rate of the stratum corneum and reducing the number of days, but the skin color In the brightness recovery test and whitening practical test, sufficient effects were not obtained.In fact, Examples 1~
20 The whitening cosmetics of the present invention have good 5F value of Xu, and especially from the day after the mouth has been exposed to sunlight, excess melanin is formed in the skin f5, so the sample is applied to Φ1. The skin on the left forearm has been clearly shown to be effective in preventing dark skin, and has an improved whitening effect compared to the right forearm.

実施例3〜8.比較例3 〔スキンクリーム〕 実施例1と同様に、下記の組成に於いて各ヤのスキンク
リームを調製して諸=式験を実悔し、その(1) 組成 を80℃にした後、(C)成分中に(B)成分を注入撹
拌混合する。次いで、撹(↑しながら温度を30℃迄冷
却する。
Examples 3-8. Comparative Example 3 [Skin Cream] In the same manner as in Example 1, skin creams of each type were prepared with the following compositions, and after various formulaic experiments, (1) After bringing the composition to 80°C, ( Inject the component (B) into the component C) and mix with stirring. Then, while stirring (↑), cool the temperature to 30°C.

尚、(A)成分のうち油溶性のものは(B)成分中に、
それ以外の成分は(C)成分中にyy);・3解してお
いた。
In addition, among the (A) components, oil-soluble ones are included in the (B) component,
The other components are yy);・3 in component (C).

(3)   特  性 第2表に示すごとく、比較例3に対して本発明の美白化
粧t4である実脩例3〜Bは諸試験に於いてすべて良好
な結果を示し、美白効果も優れていることは明らかであ
った。また、特に美白実用試験に於いては、左前腕部の
塗布部分の皮膚が色黒となることを予防する効果が向ど
しく2) 調製法 (B) 、 (C)成分を各々均一に加熱、3解して温
度(発明の効果) 以上記載の如く、本発明の美白化粧料は、皮膚支全性が
高く、メラニン色素形成抑制効果と色嘱の皮膚を速やか
に淡色化する効果を有することが明らかであり、特に太
陽光等に曝された後、速やかに使用することによって、
更に一段と美白効果が向上することが認められた。
(3) Properties As shown in Table 2, in contrast to Comparative Example 3, Examples 3 to B, which are whitening cosmetics t4 of the present invention, showed good results in all tests and had excellent whitening effects. It was clear that there were. In addition, especially in the whitening practical test, the effect of preventing the skin of the applied area on the left forearm from becoming dark skin was found to be desirable2) Preparation method (B) and (C) ingredients were heated uniformly. , 3. Temperature (Effects of the Invention) As described above, the whitening cosmetic of the present invention has high dermatotoxicity, has the effect of suppressing melanin pigment formation, and has the effect of rapidly lightening the skin color. It is clear that by using the product immediately after exposure to sunlight, etc.
Furthermore, it was observed that the whitening effect was further improved.

Claims (1)

【特許請求の範囲】[Claims] アゼライン酸のビタミンE誘導体及びその塩類の少なく
とも一種と、L−アスコルビン酸硫酸エステル塩類及び
L−アスコルビン酸リン酸エステル塩類の少なくとも一
種とを含有してなる美白化粧料。
A whitening cosmetic comprising at least one of azelaic acid vitamin E derivatives and salts thereof, and at least one of L-ascorbic acid sulfate ester salts and L-ascorbic acid phosphate ester salts.
JP29369689A 1989-11-11 1989-11-11 Skin-beautifying cosmetic Pending JPH03153610A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29369689A JPH03153610A (en) 1989-11-11 1989-11-11 Skin-beautifying cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29369689A JPH03153610A (en) 1989-11-11 1989-11-11 Skin-beautifying cosmetic

Publications (1)

Publication Number Publication Date
JPH03153610A true JPH03153610A (en) 1991-07-01

Family

ID=17798057

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29369689A Pending JPH03153610A (en) 1989-11-11 1989-11-11 Skin-beautifying cosmetic

Country Status (1)

Country Link
JP (1) JPH03153610A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05331035A (en) * 1992-05-27 1993-12-14 Sansho Seiyaku Co Ltd External preparation for skin
JP2005060248A (en) * 2003-08-14 2005-03-10 Kanebo Cosmetics Inc Cosmetic using double structure container

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05331035A (en) * 1992-05-27 1993-12-14 Sansho Seiyaku Co Ltd External preparation for skin
JP2005060248A (en) * 2003-08-14 2005-03-10 Kanebo Cosmetics Inc Cosmetic using double structure container

Similar Documents

Publication Publication Date Title
JPH03153609A (en) Skin-beautifying cosmetic
JPS61207312A (en) Skin-beautifying cosmetic
JPH0578230A (en) Skin-beautifying cosmetic
JP2663136B2 (en) Whitening cosmetics
JPH03153610A (en) Skin-beautifying cosmetic
JPH08291039A (en) Skin-lightening cosmetic
JPH0363211A (en) Cosmetic for fair skin and beauty
JPH05345717A (en) Skin cosmetic
JPH0363207A (en) Skin cosmetic
JPH0678223B2 (en) Skin cosmetics
JP3133508B2 (en) Whitening agents and whitening cosmetics
JPH09118613A (en) Skin cosmetic
JPH06256140A (en) Beautifying cosmetic
JP3045604B2 (en) Whitening cosmetics
JP3115445B2 (en) Whitening cosmetics
JPH0733639A (en) Beautifying and whitening cosmetic
JPH10147512A (en) Skin cosmetic
JP2744485B2 (en) Whitening cosmetics
JP2511816B2 (en) Whitening cosmetics
JPH0615465B2 (en) Whitening cosmetics
JPS60116616A (en) Cosmetic
JP2671244B2 (en) Whitening cosmetics
JPH05345716A (en) Skin cosmetic
JPH02138108A (en) Skin cosmetic
JPH0782135A (en) Skin cosmetic